Lanean...
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
BACKGROUND: In May, 2016, WHO endorsed a 9 month regimen for multidrug-resistant tuberculosis that is cheaper and potentially more effective than the conventional, longer (20–24 month) therapy. We aimed to investigate the population-level implications of scaling up this new regimen. METHODS: In this...
Gorde:
| Argitaratua izan da: | Lancet Respir Med |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5332590/ https://ncbi.nlm.nih.gov/pubmed/27989591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(16)30423-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|